Annual Congress on
Oncology & Cancer Research

Ondrej Slaby is a Professor of Medical Biochemistry at the the 1st Faculty of Medicine at Charles University in Prague, Czech Republic. He works as Research Group Leader at the Department of Molecular Medicine, Central European Institute of Technology (CEITEC), Masaryk University (Brno, Czech Republic) and as a Scientific Secretary at the Masaryk Memorial Cancer Institute in Brno. Prof. Slaby has published extensively in the field of non-coding RNAs and solid cancer with special focus on their translational potential in diagnostics and as the therapeutic targets (h-index 31, Sum of the times cited without auto-citations > 3500. Since 2018, prof. Slaby is a chair of Czechoslovak Biological Society. In 2010 and 2012 received Award of Czech Society for Oncology, in 2016 an Award of Czech Medical Society and 2014 and 2016 Award for Medical Research of Czech Minister of Health, Novartis Discovery Award 2017.

Molecular Medicine, Cancer Therapy

Dr. Igor F. Tsigelny is an expert in structural biology, molecular modeling, bioinformatics, structure-based drug design and personalized cancer medicine. He published >200 articles, 4 scientific books and around 15 patents. The book Protein Structure Prediction: Bioinformatic Approach that he edited has been called The Bible of all current prediction techniques by BioPlanet Bioinformatics Forums. His computational study of molecular mechanisms of Parkinson's disease was included in the US Department of Energy publication Decade of Discovery where the best computational studies of the decade 1999 - 2009 have been described. He is a Professor in the UC San Diego and CSO of CureMatch Inc. (San Diego).

Structural Biology, Molecular Modeling, Bioinformatics, Cancer Medicine

Barbara Wollenberg Professor at University Hospital Schleswig-Holstein. She studied medicine at Saarland University in Saarbrücken and at LMU Munich, Germany. She got Heisenberg Fellowship from the German Research Foundation (DFG) at the Helmholtz Centre in Munich, Germany. Barbara Wollenberg worked as a C4 professor of otorhinolaryngology and head and neck surgery at the Lübeck Campus of the University Medical Centre Schleswig-Holstein, Germany. She worked Vice dean of the Faculty of Medicine at the University of Lübeck, Germany and Review board member of the German Research Foundation (DFG). She achieved many awards like Monika Kutzner Prize for cancer research from the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW), 2001, Anton von Troeltsch Prize from the German Society of Otorhinolaryngology, Head and Neck Surgery for "Immunological therapies for patients with cancers of the head and neck", 1999. Her main specialization is in the field of Biochemistry, immunology. Apart from this she is also an eminent Specialist in otorhinolaryngology and head and neck surgery, allergology, treatment of tumours using drugs, palliative medicine, ultrasound trainer.

Her main research interest is in the field Immune system responses to tumours and Development of vaccines.

"Margaret Hjorth is currently the inaugural National Director of Nursing and Allied Health Nursing Director for Icon Cancer Centre – Australia and has a clear strategic role in the development of cancer nurses across Australia. Margaret has also held the position of chair of the Cancer Nurses Society of Australia (CNSA) Radiation Oncology Nurses Specialty Practice Network (RONSPN). This role has enabled Margaret to network with expert clinicians from across Australia to initiate and lead change in the way we care for this patient group. Margaret has a strong interest in developing resources and professional development opportunities for all cancer nurses. Margaret has developed practice principles for caring for patients undergoing radiation therapy with the aim to standardise patient care and ensure positive patient experience and patient outcomes regardless of where treatment is received. These principles will now form part of the national standards in radiation oncology within Australia. Margaret is committed to advancing nursing practice through the ongoing development and education of health professionals within the specialty and beyond."

Oncology Nursing

Mr. Nawaf is a focused, determined and capable clinical nurse specialist in emergency with a demonstrated track record of providing world class health care to his patients. He has managed volunteer works in a variety of nursing positions involving a wide range of complex & conflicting priorities. He has a power and energy to do many researches to improve nursing and emergency department in general.

Nursing

Bradford has a PhD in Medical Biochemistry-Oncology from the Roswell Park Cancer Institute, Division of SUNY at Buffalo School of Medical and Biomedical Sciences. She is the inventor of the various patents that AccuTheranostics holds. She was awarded the Award for Excellence in Research from the American Federation for Clinical Research, has authored many scientific papers and book chapters, and been an invited speaker at various international scientific meetings. Dr. Bradford is a member of many major professional cancer organizations including, ASCO, AACR and AAAS. As Chief Scientific Officer, Dr. Bradford guides the day-to-day research directives as well as the clinical laboratory operations.

--

Dental School University of Medicine and Dentistry of New Jersey 110 Bergen Street Newark

Oral Biology

Barbara DeVivo has spent her entire career in marketing management serving various executive global roles from market analysis and research, business development product management and professional relations. Ms. DeVivo has also amassed a strong proficiency in all facets of marketing management, sharing both academic and professional experiences.Currently, Ms. DeVivo is a PhD student at the State University of New York at Albany- Rockefeller College of Public Affairs and Policy whose research is centered on Organizational Behavior Management in Healthcare. Additionally, she serves as President and Founder of Extended Marketing Services, a real estate and healthcare consulting company. Ms. DeVivo has also held the position of Adjunct Professor of Marketing at the University of Memphis as well as Union Graduate College and has taught Marketing, Advertising and Brand Promotions, Market Research, and Negotiations. Furthermore, she has held the position of Executive Director of Marketing at the University of Memphis managing the operations, strategy development and execution of all marketing activities for its business school. Prior to then, Ms. DeVivo served in the healthcare industry as Director of Professional Relations for Thermage and was responsible for managing the key physician opinion leaders for the company world-wide and creating global awareness of all clinical and professional activities conducted by physicians and the company.From 2005-2007, she served as Director of Marketing for RITA Medical where she lead the company’s drug eluting therapy efforts in the oncology market for the treatment of nonresectable metastatic liver, lung and kidney tumors, broke through and built the US market with a novel procedure and served the company through product management, business development and market analysis for emerging businesses. Prior to RITA, Ms. DeVivo worked for CR Bard managing the company’s brachytherapy oncology business for the treatment of prostate and breast cancer.

Healthcare Management and Organizational Management

Michael Retsky (PhD in Physics from University of Chicago) made a career change to cancer research thirty years ago. He was on Judah Folkman’s staff at Harvard Medical School for 12 years. Diagnosed with stage IIIc colon cancer in 1994, he opted for a low dose long term chemotherapy protocol that is now called metronomic chemotherapy. Retsky is Editor and Romano Demicheli is Co-Editor of a Springer/Nature book on breast cancer published in July 2017. Retsky is a founder of the Colon Cancer Alliance and has published more than 90 papers in physics and cancer.

Physics, Charged particle optics, Oncology

Will be updated

Nursing, Pediatric Oncology

Dr. Bhattacharjee did her B.Sc in Biotechnology from Bangalore University in 2006 and M.Sc in Applied Genetics from Bangalore University in 2008. She then moved to England to pursue her DPhil (Phd) in Biochemistry from Oxford University where she studied the role of Fml1 and its partner proteins Mhf1 and Mhf2 in promoting genome stability. She was awarded her DPhil in 2012. During her time at Oxford, she was also a tutor at Greene College, Oxford. In 2013, Dr. Bhattacharjee moved to Cold Spring Harbor Laboratory, New York.

Her work has focused on understanding the epigenetic regulation of DNA repair. She is also an academic tutor at the Watson School of Biological studies, the school for graduate studies at CSHL